{"entity":{"entity_id":"457b218b-1ea7-4303-86f6-5e33dd718802","entity_url":"https://factanker.com/entity/457b218b-1ea7-4303-86f6-5e33dd718802","label":"BIOCRYST PHARMACEUTICALS, INC.","type":"org","anchors":{"cik":"0000882796","qid":"Q4914611"}},"answer":"In fiscal year 2025, US federal obligations equal -3.3% of BIOCRYST PHARMACEUTICALS, INC.'s reported revenue - $-28.8M in federal awards against $874.8M in revenue as filed with the SEC.","cite_as":"FACTANKER, https://factanker.com/entity/457b218b-1ea7-4303-86f6-5e33dd718802/government-dependency","method":"EDGAR revenue (company fiscal year) against USAspending obligations (federal fiscal year of the award date); identity via evidence-backed same_as facts.","series":[{"company":"BIOCRYST PHARMACEUTICALS, INC.","cik":"0000882796","lei":"549300Z0INP1Z5NP6J59","qid":"Q4914611","uei":"MGXADJ6SCLJ5","ein":null,"fiscal_year":2026,"revenue_usd":null,"obligations_usd":13248.84,"awards":10,"gov_share":null,"data_completeness":"complete"},{"company":"BIOCRYST PHARMACEUTICALS, INC.","cik":"0000882796","lei":"549300Z0INP1Z5NP6J59","qid":"Q4914611","uei":"MGXADJ6SCLJ5","ein":null,"fiscal_year":2025,"revenue_usd":874837000.0,"obligations_usd":-28792410.57,"awards":11,"gov_share":-0.0329,"data_completeness":"complete"},{"company":"BIOCRYST PHARMACEUTICALS, INC.","cik":"0000882796","lei":"549300Z0INP1Z5NP6J59","qid":"Q4914611","uei":"MGXADJ6SCLJ5","ein":null,"fiscal_year":2024,"revenue_usd":450712000.0,"obligations_usd":2658743.18,"awards":10,"gov_share":0.0059,"data_completeness":"complete"},{"company":"BIOCRYST PHARMACEUTICALS, INC.","cik":"0000882796","lei":"549300Z0INP1Z5NP6J59","qid":"Q4914611","uei":"MGXADJ6SCLJ5","ein":null,"fiscal_year":2023,"revenue_usd":331412000.0,"obligations_usd":-198571.04,"awards":4,"gov_share":-0.0006,"data_completeness":"complete"},{"company":"BIOCRYST PHARMACEUTICALS, INC.","cik":"0000882796","lei":"549300Z0INP1Z5NP6J59","qid":"Q4914611","uei":"MGXADJ6SCLJ5","ein":null,"fiscal_year":2022,"revenue_usd":270827000.0,"obligations_usd":7826590.97,"awards":7,"gov_share":0.0289,"data_completeness":"complete"},{"company":"BIOCRYST PHARMACEUTICALS, INC.","cik":"0000882796","lei":"549300Z0INP1Z5NP6J59","qid":"Q4914611","uei":"MGXADJ6SCLJ5","ein":null,"fiscal_year":2021,"revenue_usd":157170000.0,"obligations_usd":8315666.0,"awards":7,"gov_share":0.0529,"data_completeness":"contracts_only"},{"company":"BIOCRYST PHARMACEUTICALS, INC.","cik":"0000882796","lei":"549300Z0INP1Z5NP6J59","qid":"Q4914611","uei":"MGXADJ6SCLJ5","ein":null,"fiscal_year":2020,"revenue_usd":17812000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"BIOCRYST PHARMACEUTICALS, INC.","cik":"0000882796","lei":"549300Z0INP1Z5NP6J59","qid":"Q4914611","uei":"MGXADJ6SCLJ5","ein":null,"fiscal_year":2019,"revenue_usd":48835000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"BIOCRYST PHARMACEUTICALS, INC.","cik":"0000882796","lei":"549300Z0INP1Z5NP6J59","qid":"Q4914611","uei":"MGXADJ6SCLJ5","ein":null,"fiscal_year":2018,"revenue_usd":20653000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"BIOCRYST PHARMACEUTICALS, INC.","cik":"0000882796","lei":"549300Z0INP1Z5NP6J59","qid":"Q4914611","uei":"MGXADJ6SCLJ5","ein":null,"fiscal_year":2017,"revenue_usd":25186000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"BIOCRYST PHARMACEUTICALS, INC.","cik":"0000882796","lei":"549300Z0INP1Z5NP6J59","qid":"Q4914611","uei":"MGXADJ6SCLJ5","ein":null,"fiscal_year":2016,"revenue_usd":26353000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"BIOCRYST PHARMACEUTICALS, INC.","cik":"0000882796","lei":"549300Z0INP1Z5NP6J59","qid":"Q4914611","uei":"MGXADJ6SCLJ5","ein":null,"fiscal_year":2015,"revenue_usd":48257000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"BIOCRYST PHARMACEUTICALS, INC.","cik":"0000882796","lei":"549300Z0INP1Z5NP6J59","qid":"Q4914611","uei":"MGXADJ6SCLJ5","ein":null,"fiscal_year":2014,"revenue_usd":13608000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"BIOCRYST PHARMACEUTICALS, INC.","cik":"0000882796","lei":"549300Z0INP1Z5NP6J59","qid":"Q4914611","uei":"MGXADJ6SCLJ5","ein":null,"fiscal_year":2013,"revenue_usd":17331000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"BIOCRYST PHARMACEUTICALS, INC.","cik":"0000882796","lei":"549300Z0INP1Z5NP6J59","qid":"Q4914611","uei":"MGXADJ6SCLJ5","ein":null,"fiscal_year":2012,"revenue_usd":26293000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"BIOCRYST PHARMACEUTICALS, INC.","cik":"0000882796","lei":"549300Z0INP1Z5NP6J59","qid":"Q4914611","uei":"MGXADJ6SCLJ5","ein":null,"fiscal_year":2011,"revenue_usd":19643000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"BIOCRYST PHARMACEUTICALS, INC.","cik":"0000882796","lei":"549300Z0INP1Z5NP6J59","qid":"Q4914611","uei":"MGXADJ6SCLJ5","ein":null,"fiscal_year":2010,"revenue_usd":62381000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null},{"company":"BIOCRYST PHARMACEUTICALS, INC.","cik":"0000882796","lei":"549300Z0INP1Z5NP6J59","qid":"Q4914611","uei":"MGXADJ6SCLJ5","ein":null,"fiscal_year":2009,"revenue_usd":74590000.0,"obligations_usd":null,"awards":null,"gov_share":null,"data_completeness":null}],"not_claimed":["Obligations are federal fiscal years (Oct–Sep), revenue is the company's fiscal year — the periods do not align exactly.","For years with data_completeness='contracts_only' only contracts are loaded, assistance is still missing — for grant recipients the total is therefore too low."],"retrieved_at":"2026-10-24T04:47:18"}